Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
10.1371/journal.pone.0090176
Saved in:
Main Authors: | Ann Chai, L.Y., Kullberg, B.J., Earnest, A., Johnson, E.M., Teerenstra, S., Vonk, A.G., Schlamm, H.T., Herbrecht, R., Netea, M.G., Troke, P.F. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110345 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity
by: Chai, L.Y.A., et al.
Published: (2014) -
Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis
by: Pang, L, et al.
Published: (2023) -
Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis
by: Praniti Danpornprasert, et al.
Published: (2018) -
Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
by: Hsu, L.Y., et al.
Published: (2016) -
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients
by: Khuanchai Supparatpinyo, et al.
Published: (2018)